Global Oncology Injectables Market to Grow at 11.17% During 2022-2027, Catalyzed by Increasing Incidences of Cancer

September 30, 2020

According to the latest report by IMARC Group, titled "Oncology Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global oncology injectables market is expected to grow at a CAGR of 11.17% during 2022-2027. Oncology injectables are intravenous drugs that are widely used for the treatment of different forms of cancer. These drugs are administered directly in the bloodstream of the patient to improve its biological effect. Extensively available in liquid form, these injectables aid in mitigating the growth of cancer-inducing proteins while destroying the malignant cells formed in the body. These drugs are usually preferred by healthcare professionals for cancer treatments as they provide improved efficiency, increased bioavailability, better compliance and reduced gastrointestinal irritation.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Oncology Injectables Market Trends:

The market is primarily driven by the increasing prevalence of various forms of cancer across the globe. This, along with the growing awareness regarding early cancer detection among the masses, is providing a thrust to the market growth. This is further supported by the easy accessibility to chemotherapy treatments and improving healthcare infrastructure on the global level. There has been a significant increase in the investments by drug manufacturers and biotechnology companies for developing new anti-cancer intravenous drugs, which is acting as another major growth-inducing factor. These injectables are expected to be highly efficient and target-oriented with minimal side effects. This, coupled with the faster drug approvals from several regulatory bodies, including the US Food and Drug Administration (FDA), is anticipated to create a positive outlook for the market. Moreover, the growing preference for multiple generic oncology injectables by patients on account of the cost-efficient nature of these drugs is providing an impetus to the market growth. Some of the other factors contributing to the market growth include the increasing penetration of healthcare insurance and the rising trend of medical tourism on the global level.

Market Summary:

  • On the basis of the molecule type, the market has been bifurcated into small and large molecule.
  • Based on the product type, the market has been divided into chemotherapy, monoclonal antibodies, cytokines and peptide hormones.
  • On the basis of the indication, the market has been classified into lung, breast, colorectal, prostate, stomach, liver, esophagus, cervical and other types of cancers.
  • The market has been categorized into branded and generics.
  • On the basis of the distribution channel, the market has been segmented into retail, hospital and online pharmacies.
  • On the geographical front, the market has been segregated into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa (Turkey, Saudi Arabia and others).
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Global Oncology Injectables Market to Grow at 11.17% During 2022-2027, Catalyzed by Increasing Incidences of Cancer
Select Licence Type

Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More